Verastem (VSTM) Net Cash Flow (2011 - 2026)
Verastem (VSTM) recorded quarterly Net Cash Flow of -$39.4 million in Q1 2026, down 158.62% quarter-over-quarter from $67.3 million in Q4 2025, and down 237.17% on a YoY basis from $28.8 million in Q1 2025.
Verastem (VSTM) Net Cash Flow (2011 - 2026) Analysis & Trends
Verastem's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$39.4 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 237.17% year-over-year to -$39.4 million; the TTM figure through Mar 2026 stood at $56.3 million (up 59.76% YoY), while the FY2025 annual figure was $116.2 million, up 1063.7% from the prior year.
- Net Cash Flow was -$39.4 million for Q1 2026 at Verastem, down from $67.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $85.6 million in Q2 2023 to a low of -$87.6 million in Q3 2023.
- Historically, Net Cash Flow has averaged $9.0 million across 5 years, with a median of $15.2 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow tumbled 676.46% in 2023, then surged 4492.63% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$3.6 million in 2022, then sank by 392.65% to -$17.7 million in 2023, then sank by 37.68% to -$24.4 million in 2024, then surged by 376.24% to $67.3 million in 2025, then sank by 158.62% to -$39.4 million in 2026.
- The last three Net Cash Flow figures came in at -$39.4 million (Q1 2026), $67.3 million (Q4 2025), and -$18.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -39.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.44 Mn |
| Mar 31, 2026 | -39.44 Mn |
| Dec 31, 2025 | 67.28 Mn |
| Dec 31, 2025 | 67.28 Mn |
| Sep 30, 2025 | -18.34 Mn |
| Sep 30, 2025 | -18.34 Mn |
| Jun 30, 2025 | 46.75 Mn |
| Jun 30, 2025 | 46.75 Mn |
| Mar 31, 2025 | 28.75 Mn |
| Mar 31, 2025 | 28.75 Mn |
| Dec 31, 2024 | -24.36 Mn |
| Dec 31, 2024 | -24.36 Mn |
| Sep 30, 2024 | 29.80 Mn |
| Sep 30, 2024 | 29.80 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | -17.69 Mn |
| Dec 31, 2023 | -17.69 Mn |